BREAST CANCER

July 8, 2021

Choosing Between an Aromatase Inhibitor or Tamoxifen in Perimenopausal Patients

July 8, 2021

Assessing the Efficacy and Safety of PARP Inhibitors in Breast Cancer

July 8, 2021

Statins May Lower HF Risk in BC Patients on Anthracycline Chemotherapy

June 11, 2021

Breast Cancer: Not Just a Female Disease

June 4, 2021

Preventing Breast Cancer in High-Risk Patients

June 4, 2021

Progesterone Receptor–Negative Breast Cancer Predicts Worse Outcome

June 4, 2021

Is the 21-Gene Assay Useful in Predicting Endocrine Therapy Response?

May 13, 2021

Risk Factors With Hand-Foot Syndrome in Breast Cancer

May 13, 2021

Repurposing Drugs for Breast Cancer

May 13, 2021

Endocrine Therapy Does Not Increase Dementia Risk

April 8, 2021

Do Women Who Switch to Letrozole Maintain Estrogen Suppression?

April 8, 2021

Increased Risk of Cardiovascular Disease in Older Female BC Survivors

April 8, 2021

Limited Benefit of Pembrolizumab Monotherapy in Metastatic TNBC

July 2021

July 2021

In This Issue Digital Magazine Archives Subscription

Copyright © 2000 - 2021 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.